跳至主要内容
临床试验/NCT01230905
NCT01230905已完成4 期

Does Androgen Suppression Treatment In Prostate Cancer Reduce Myocardial Blood Flow Reserve?

Ottawa Heart Institute Research Corporation2 个研究点 分布在 1 个国家目标入组 181 人开始时间: 2008年7月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
181
试验地点
2
主要终点
myocardial flow reserve

研究概览

简要总结

Suppression of effects of androgens with male sex hormones, androgen suppression treatment (AST), has been known to reduce deaths and prolong life in advanced prostate cancer. There have, however, been concerns raised in previous studies that androgen suppression may be associated with increased rate of heart attacks, particularly in older men. This study looks at prostate cancer patients in The Ottawa Hospital Cancer Clinic to see if treating these patients with androgen suppression is associated with a decrease in blood flow to the heart muscles by using Positron Emission Tomography (PET) and brachial artery ultrasound.

详细描述

Treatment group: Prior to the initiation of AST, subjects will have a baseline N-13-ammonia PET scan and a brachial artery ultrasound at the University of Ottawa Heart Institute. Blood glucose and a lipid profile will be obtained. These tests will be repeated 6 - 9 months after starting AST.

Cancer control group: The same testing and intervals will be performed. Normals control group: Baseline testing will be done to establish a normal.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Cancer Population:
  • Diagnosis of prostate cancer
  • Treatment group: Scheduled to start AST, at Ottawa Hospital under the care of Radiation Oncology, Urology or Medical Oncology.
  • Control group: no AST scheduled as a treatment option for prostate cancer.
  • Non-Cancer Control Group
  • Male with low pre-test likelihood of coronary artery disease
  • No previous history of cancer.

排除标准

  • Known coronary disease including any of previous revascularization, history of myocardial infarction, coronary disease with >= 50% stenosis in a major coronary vessel on previous angiography, evidence of previous myocardial infarction on 12-lead electrocardiogram, positive myocardial perfusion scan, previous cardiac PET scan, stress echocardiogram or exercise stress test.
  • Subjects with a Summed Stress Score of >4 attributed to coronary disease on baseline PET images
  • Patients previously treated with AST
  • Patients with a life expectancy of less than 1 year.

结局指标

主要结局

myocardial flow reserve

时间窗: 6 - 9 months

The change in global absolute MFR between baseline and follow up PET studies, at a patient level. MFR is defined as the ratio between regional blood flow with maximum vasodilation and baseline regional blood flow.

次要结局

  • Regional myocardial perfusion(6 - 9 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Terrence Ruddy

Principal Investigator

Ottawa Heart Institute Research Corporation

研究点 (2)

Loading locations...

相似试验